Global Companion Animal Vaccines Market Research Report 2025(Status and Outlook)
Description
Report Overview
The global companion animal vaccines market is a rapidly growing segment within the veterinary healthcare industry, driven by increasing pet ownership, rising awareness of zoonotic diseases, and advancements in vaccine technology. Companion animal vaccines are biological preparations designed to stimulate immune responses in pets, primarily dogs and cats, against infectious diseases such as rabies, distemper, parvovirus, feline leukemia, and kennel cough. The market is characterized by a mix of core vaccines (mandatory for all pets) and non-core vaccines (administered based on lifestyle and risk factors). Key players include multinational pharmaceutical companies, veterinary healthcare providers, and biotech firms investing in innovative formulations, such as recombinant and DNA vaccines. Growth is further supported by regulatory mandates for rabies vaccination, the expansion of veterinary clinics, and pet humanization trends, where owners prioritize preventive healthcare. However, challenges such as vaccine hesitancy, high costs in emerging markets, and logistical constraints in cold-chain distribution may hinder market expansion. Geographically, North America and Europe dominate due to high pet adoption rates and advanced veterinary infrastructure, while Asia-Pacific is emerging as a high-growth region due to increasing disposable income and urbanization.
The global Companion Animal Vaccines market size was estimated at USD 1890.8 million in 2024, exhibiting a CAGR of 6.50% during the forecast period.
This report provides a deep insight into the global Companion Animal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Animal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Animal Vaccines market in any manner.
Global Companion Animal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial
Market Segmentation (by Type)
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Market Segmentation (by Application)
Canine
Avian
Feline
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Animal Vaccines Market
Overview of the regional outlook of the Companion Animal Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Animal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Animal Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The global companion animal vaccines market is a rapidly growing segment within the veterinary healthcare industry, driven by increasing pet ownership, rising awareness of zoonotic diseases, and advancements in vaccine technology. Companion animal vaccines are biological preparations designed to stimulate immune responses in pets, primarily dogs and cats, against infectious diseases such as rabies, distemper, parvovirus, feline leukemia, and kennel cough. The market is characterized by a mix of core vaccines (mandatory for all pets) and non-core vaccines (administered based on lifestyle and risk factors). Key players include multinational pharmaceutical companies, veterinary healthcare providers, and biotech firms investing in innovative formulations, such as recombinant and DNA vaccines. Growth is further supported by regulatory mandates for rabies vaccination, the expansion of veterinary clinics, and pet humanization trends, where owners prioritize preventive healthcare. However, challenges such as vaccine hesitancy, high costs in emerging markets, and logistical constraints in cold-chain distribution may hinder market expansion. Geographically, North America and Europe dominate due to high pet adoption rates and advanced veterinary infrastructure, while Asia-Pacific is emerging as a high-growth region due to increasing disposable income and urbanization.
The global Companion Animal Vaccines market size was estimated at USD 1890.8 million in 2024, exhibiting a CAGR of 6.50% during the forecast period.
This report provides a deep insight into the global Companion Animal Vaccines market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Companion Animal Vaccines Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Companion Animal Vaccines market in any manner.
Global Companion Animal Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bayer
Vetoquinol
Boehringer Ingelheim
Ceva
Eli Lilly
Heska
Merck
Merial
Market Segmentation (by Type)
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
DNA Vaccines
Recombinant Vaccines
Market Segmentation (by Application)
Canine
Avian
Feline
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Animal Vaccines Market
Overview of the regional outlook of the Companion Animal Vaccines Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Animal Vaccines Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Animal Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
139 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Companion Animal Vaccines
- 1.2 Key Market Segments
- 1.2.1 Companion Animal Vaccines Segment by Type
- 1.2.2 Companion Animal Vaccines Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Companion Animal Vaccines Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Companion Animal Vaccines Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Companion Animal Vaccines Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Companion Animal Vaccines Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Companion Animal Vaccines Product Life Cycle
- 3.3 Global Companion Animal Vaccines Sales by Manufacturers (2020-2025)
- 3.4 Global Companion Animal Vaccines Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Companion Animal Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Companion Animal Vaccines Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Companion Animal Vaccines Market Competitive Situation and Trends
- 3.8.1 Companion Animal Vaccines Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Companion Animal Vaccines Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Companion Animal Vaccines Industry Chain Analysis
- 4.1 Companion Animal Vaccines Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Companion Animal Vaccines Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Companion Animal Vaccines Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Companion Animal Vaccines Market
- 5.7 ESG Ratings of Leading Companies
- 6 Companion Animal Vaccines Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Companion Animal Vaccines Sales Market Share by Type (2020-2025)
- 6.3 Global Companion Animal Vaccines Market Size Market Share by Type (2020-2025)
- 6.4 Global Companion Animal Vaccines Price by Type (2020-2025)
- 7 Companion Animal Vaccines Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Companion Animal Vaccines Market Sales by Application (2020-2025)
- 7.3 Global Companion Animal Vaccines Market Size (M USD) by Application (2020-2025)
- 7.4 Global Companion Animal Vaccines Sales Growth Rate by Application (2020-2025)
- 8 Companion Animal Vaccines Market Sales by Region
- 8.1 Global Companion Animal Vaccines Sales by Region
- 8.1.1 Global Companion Animal Vaccines Sales by Region
- 8.1.2 Global Companion Animal Vaccines Sales Market Share by Region
- 8.2 Global Companion Animal Vaccines Market Size by Region
- 8.2.1 Global Companion Animal Vaccines Market Size by Region
- 8.2.2 Global Companion Animal Vaccines Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Companion Animal Vaccines Sales by Country
- 8.3.2 North America Companion Animal Vaccines Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Companion Animal Vaccines Sales by Country
- 8.4.2 Europe Companion Animal Vaccines Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Companion Animal Vaccines Sales by Region
- 8.5.2 Asia Pacific Companion Animal Vaccines Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Companion Animal Vaccines Sales by Country
- 8.6.2 South America Companion Animal Vaccines Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Companion Animal Vaccines Sales by Region
- 8.7.2 Middle East and Africa Companion Animal Vaccines Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Companion Animal Vaccines Market Production by Region
- 9.1 Global Production of Companion Animal Vaccines by Region(2020-2025)
- 9.2 Global Companion Animal Vaccines Revenue Market Share by Region (2020-2025)
- 9.3 Global Companion Animal Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Companion Animal Vaccines Production
- 9.4.1 North America Companion Animal Vaccines Production Growth Rate (2020-2025)
- 9.4.2 North America Companion Animal Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Companion Animal Vaccines Production
- 9.5.1 Europe Companion Animal Vaccines Production Growth Rate (2020-2025)
- 9.5.2 Europe Companion Animal Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Companion Animal Vaccines Production (2020-2025)
- 9.6.1 Japan Companion Animal Vaccines Production Growth Rate (2020-2025)
- 9.6.2 Japan Companion Animal Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Companion Animal Vaccines Production (2020-2025)
- 9.7.1 China Companion Animal Vaccines Production Growth Rate (2020-2025)
- 9.7.2 China Companion Animal Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Bayer
- 10.1.1 Bayer Basic Information
- 10.1.2 Bayer Companion Animal Vaccines Product Overview
- 10.1.3 Bayer Companion Animal Vaccines Product Market Performance
- 10.1.4 Bayer Business Overview
- 10.1.5 Bayer SWOT Analysis
- 10.1.6 Bayer Recent Developments
- 10.2 Vetoquinol
- 10.2.1 Vetoquinol Basic Information
- 10.2.2 Vetoquinol Companion Animal Vaccines Product Overview
- 10.2.3 Vetoquinol Companion Animal Vaccines Product Market Performance
- 10.2.4 Vetoquinol Business Overview
- 10.2.5 Vetoquinol SWOT Analysis
- 10.2.6 Vetoquinol Recent Developments
- 10.3 Boehringer Ingelheim
- 10.3.1 Boehringer Ingelheim Basic Information
- 10.3.2 Boehringer Ingelheim Companion Animal Vaccines Product Overview
- 10.3.3 Boehringer Ingelheim Companion Animal Vaccines Product Market Performance
- 10.3.4 Boehringer Ingelheim Business Overview
- 10.3.5 Boehringer Ingelheim SWOT Analysis
- 10.3.6 Boehringer Ingelheim Recent Developments
- 10.4 Ceva
- 10.4.1 Ceva Basic Information
- 10.4.2 Ceva Companion Animal Vaccines Product Overview
- 10.4.3 Ceva Companion Animal Vaccines Product Market Performance
- 10.4.4 Ceva Business Overview
- 10.4.5 Ceva Recent Developments
- 10.5 Eli Lilly
- 10.5.1 Eli Lilly Basic Information
- 10.5.2 Eli Lilly Companion Animal Vaccines Product Overview
- 10.5.3 Eli Lilly Companion Animal Vaccines Product Market Performance
- 10.5.4 Eli Lilly Business Overview
- 10.5.5 Eli Lilly Recent Developments
- 10.6 Heska
- 10.6.1 Heska Basic Information
- 10.6.2 Heska Companion Animal Vaccines Product Overview
- 10.6.3 Heska Companion Animal Vaccines Product Market Performance
- 10.6.4 Heska Business Overview
- 10.6.5 Heska Recent Developments
- 10.7 Merck
- 10.7.1 Merck Basic Information
- 10.7.2 Merck Companion Animal Vaccines Product Overview
- 10.7.3 Merck Companion Animal Vaccines Product Market Performance
- 10.7.4 Merck Business Overview
- 10.7.5 Merck Recent Developments
- 10.8 Merial
- 10.8.1 Merial Basic Information
- 10.8.2 Merial Companion Animal Vaccines Product Overview
- 10.8.3 Merial Companion Animal Vaccines Product Market Performance
- 10.8.4 Merial Business Overview
- 10.8.5 Merial Recent Developments
- 11 Companion Animal Vaccines Market Forecast by Region
- 11.1 Global Companion Animal Vaccines Market Size Forecast
- 11.2 Global Companion Animal Vaccines Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Companion Animal Vaccines Market Size Forecast by Country
- 11.2.3 Asia Pacific Companion Animal Vaccines Market Size Forecast by Region
- 11.2.4 South America Companion Animal Vaccines Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Companion Animal Vaccines by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Companion Animal Vaccines Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Companion Animal Vaccines by Type (2026-2033)
- 12.1.2 Global Companion Animal Vaccines Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Companion Animal Vaccines by Type (2026-2033)
- 12.2 Global Companion Animal Vaccines Market Forecast by Application (2026-2033)
- 12.2.1 Global Companion Animal Vaccines Sales (K MT) Forecast by Application
- 12.2.2 Global Companion Animal Vaccines Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
